Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 8 of 663 for:    SMS

Immunization Schedule Alert Platform (ISAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03705455
Recruitment Status : Not yet recruiting
First Posted : October 15, 2018
Last Update Posted : October 15, 2018
Sponsor:
Information provided by (Responsible Party):
Dr.Ihedioha Emmanuel Chukwunwike, Lifespan Healthcare Resource Limited

Brief Summary:
The ISAP study is investigating the efficacy of SMS messages in improving routine childhood Immunization timeliness and completeness in Nigeria.

Condition or disease Intervention/treatment Phase
Immunization Behavioral: ISAP SMS Not Applicable

Detailed Description:
The ISAP - Immunization Schedule Alert Platform study is investigating the efficacy of ISAP SMS exposure to Caregivers with children( who have fulfilled our inclusion criteria) due for routine childhood Immunisation in influencing decision for timely and complete Immunization uptake. ISAP SMS messages contains information on the Immunization appointment schedule, time ,vaccine to be administered and the address of the Immunization centre.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1800 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Immunization Schedule Alert Platform: Determining ISAP SMS Efficacy in Improving Childhood Immunization Timeliness and Completeness in Nigeria
Estimated Study Start Date : November 1, 2018
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2019

Arm Intervention/treatment
Active Comparator: ISAP SMS
ISAP SMS will be sent to enrolled caregivers
Behavioral: ISAP SMS
ISAP SMS is a text message for caregivers use that provides immunization schedule and vaccine availability at the nearest immunization clinic.

No Intervention: No ISAP SMS
No ISAP SMS will be sent to enrolled caregivers



Primary Outcome Measures :
  1. Proportion of timely and complete vaccine uptake after ISAP SMS Intervention [ Time Frame: 12 months ]
    Proportion of timely and complete vaccine uptake after ISAP SMS Intervention



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Weeks to 12 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Caregiver with child due for birth dose vaccination or at 6weeks-OPV1,Penta1,PCV1,Rota1.

Exclusion Criteria: Caregiver with child who have already had OPV1,Penta1,PCV1and Rota1.

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03705455


Contacts
Layout table for location contacts
Contact: Emmanuel Ihedioha, MBBS 23407038861841 ext 23407038861841 emmanuel.ihedioha@lifespanhcr.com

Locations
Layout table for location information
Nigeria
Nkanu East Health centre Immunization clinic Recruiting
Enugu, Nigeria
Contact: Ani         
Contact    2348101313587    ckprime2000@yahoo.co.uk   
Sponsors and Collaborators
Lifespan Healthcare Resource Limited
Investigators
Layout table for investigator information
Principal Investigator: Emmanuel Ihedioha, MBBS Lifespan Healthcare Resource

Layout table for additonal information
Responsible Party: Dr.Ihedioha Emmanuel Chukwunwike, Principal Investigator, Lifespan Healthcare Resource Limited
ClinicalTrials.gov Identifier: NCT03705455     History of Changes
Other Study ID Numbers: OPP1182651
First Posted: October 15, 2018    Key Record Dates
Last Update Posted: October 15, 2018
Last Verified: October 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Vaccines
Immunologic Factors
Physiological Effects of Drugs